Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 13.09
0.615 %
$ 1.72 B
Market Cap
87.27
P/E
Price Target
Average
87.17%
Revenue Forecast
Estimate
36.05%
EBIT
Estimate
--63.03%
Net Income
Estimate
180.86%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Dynavax Technologies Corporation
Wall Street analysts predict an average 1-year price target for DVAX of $24.5 , with forecasts ranging from
a
low of
$20 to a high of $29 .
DVAX Lowest Price Target
Wall Street Target
20 USD
52.79%
DVAX Average Price Target
Wall Street Target
24.5 USD
87.17%
DVAX Highest Price Target
Wall Street Target
29 USD
121.54%
REVENUE FORECAST
Revenue Forecast Chart DVAX
EBIT FORECAST
EBIT Forecast Chart DVAX
NET INCOME FORECAST
Net Income Chart DVAX